A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP)

Journal of Infection and Chemotherapy

Volumn 19, Issue 4, 2013, Pages 719-726

  Fukuyama, Hajime ^a   Yamashiro, Shin ^a   Tamaki, Hitoshi ^a   Kishaba, Tomoo ^a  

^a Okinawa Prefectural Chubu Hospital   (Japan)

Author keywords

Aspiration pneumonia; Atypical pathogens; Community acquired pneumonia; Multidrug resistant pathogens; Nursing and healthcare associated pneumonia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; LEVOFLOXACIN; MACROLIDE; MINOCYCLINE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; ASPIRATION PNEUMONIA; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; MULTIDRUG RESISTANCE; NURSING AND HEALTHCARE ASSOCIATED PNEUMONIA; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PNEUMONIA, ASPIRATION; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84882276327     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-013-0557-1     Document Type: Article

References (37)

1. American Thoracic Society. Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
2. The committee for the Japanese Respiratory Society guidelines for the management of nursing and healthcare-associated pneumonia. The Japanese Respiratory Society guidelines for the management of nursing and healthcare-associated pneumonia. The Japanese Respiratory Society, Tokyo, 2011. Article in Japanese.
3. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-55.
4. Committee for the Japanese Respiratory Society guidelines for the management of respiratory infections. Guidelines for the management of community-acquired pneumonia in adults, revised edition. Respirology. 2006;11(Suppl 3):S79-133.
5. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377-82.
6. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-50.
7. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of adults with community acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-72.
8. Japanese Respiratory Society. The Japanese Respiratory Society guidelines for the management of hospital-acquired pneumonia in adults. Respirology. 2009;14(suppl 2):S1-71.
9. Marrie TJ, Huang JQ. Community-acquired pneumonia in patients receiving home care. J Am Geriatr Soc. 2005;53:834-9.
10. Fukuyama H, Ishida T, Tachibana H, Iga C, Nakagawa H, Ito A, et al. Clinical evaluation of bedridden patients with pneumonia receiving home health care. Nihon Kokyuki Gakkai Zassi. 2010;48:906-11. Article in Japanese, abstract in English.
11. Sekizawa K, Ujiie Y, Itabashi S, Sasaki H, Takishima T. Lack of cough reflex in aspiration pneumonia. Lancet. 1990;335:1228-9.
12. Horner J, Massey EW, Riski JE, Lathrop DL, Chase KN. Aspiration following stroke: clinical correlates and outcome. Neurology. 1988;38:1359-62.
13. Ebihara S, Saito H, Kanda A, Nakajoh M, Takahashi H, Arai H, et al. Impaired efficacy of cough in patients with Parkinson disease. Chest. 2003;124:1009-15.
14. Wada H, Nakajoh K, Satoh-Nakagawa T, Suzuki T, Ohrui T, Arai H, et al. Risk factors of aspiration pneumonia in Alzheimer's disease patients. Gerontology. 2001;47:271-6.
15. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128:3854-62.
16. Carratalà J, Mykietiuk A, Fernández-Sabé N, Suárez C, Dorca J, Verdaguer R, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med. 2007;167:1393-9.
17. Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Hashimoto N, et al. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest. 2009;135:633-40.
18. Lim WS, Macfarlane JT. A prospective comparison of nursing home-acquired pneumonia with community-acquired pneumonia. Eur Respir J. 2001;18:362-8.
19. Maruyama T, Niederman MS, Kobayashi T, Kobayashi H, Takagi T, D'Alessandro-Gabazza CN, et al. A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respir Med. 2008;102:1287-95.
20. Ewig S, Klapdor B, Pletz MW, Rohde G, Schütte H, Schaberg T, et al. Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study. Thorax. 2012;67:132-8.
21. Miyashita M, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, et al. Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital. Intern Med. 2012;51:585-94.
22. Kaku N, Yanagihara K, Morinaga Y, Izumikawa K, Nagashima S, Kakeya H, et al. The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP). J Infect Chemother. 2012. doi: 10.1007/s10156-012-0454-z.
23. Ishida T, Tachibana H, Ito A, Yoshioka H, Arita M, Hashimoto T. Clinical characteristics of nursing and healthcare-associated pneumonia: a Japanese variant of healthcare-associated pneumonia. Intern Med. 2012;51:2537-44.
24. Yoneyama T, Yoshida M, Ohrui T, Mukaiyama H, Okamoto H, Hoshiba K, et al. Oral care reduces pneumonia in older patients in nursing homes. J Am Geriatr Soc. 2002;50:430-3.
25. Sura L, Madhavan A, Carnaby G, Crary MA. Dysphagia in the elderly: management and nutritional considerations. Clin Interv Aging. 2012;7:287-98. doi: 10.2147/CIA.S23404.
26. Park HK, Song JU, Um SW, Koh WJ, Suh GY, Chung MP, et al. Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Respir Med. 2010;104:1729-35.
27. Chalmers JD, Taylor JK, Singanayagam A, Fleming GB, Akram AR, Mandal P, et al. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis. 2011;53:107-13.
28. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother. 2007;51:3568-73.
29. Brito V, Niederman MS. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis. 2009;22:316-25.
30. Ewig S, Welte T, Chastre J, Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis. 2010;10:279-87.
31. Schreiber MP, Chan CM, Shorr AF. Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? Chest. 2010;137:1283-8.
32. von Baum H, Welte T, Marre R, Suttorp N. CAPNETZ study group. Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors. Eur Respir J. 2010;35:598-605.
33. Kett DH, Cano E, Quartin AA, Mangino JE, Zervos MJ, Peyrani P, et al. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicenter cohort study. Lancet Infect Dis. 2011;11:181-9.
34. Attridge RT, Frei CR, Restrepo MI, Lawson KA, Ryan L, Pugh MJ, et al. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J. 2011;38:878-87.
35. Webb BJ, Dangerfield BS, Pasha JS, Agrwal N, Vikram HR. Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia. Respir Med. 2012;106:1606-12.
36. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003;37:1405-33.
37. Rello J, Luján M, Gallego M, Vallés J, Belmonte Y, Fontanals D, et al. Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia. Chest. 2010;137:1138-44.